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There are no contemporary data available describing human
immunity to novel inﬂuenza A/H7N9. Using 1723 prospec-
tively collected serum samples in southern Vietnam, we
tested for antibodies to 5 avian inﬂuenza virus antigens,
using a protein microarray. General-population antibody
titers against subtype H7 virus are higher than antibody
titers against subtype H5 and lower than titers against H9.
The highest titers were observed for human inﬂuenza virus
subtypes. Titers to avian inﬂuenza virus antigens increased
with age and with geometric mean antibody titer to human
inﬂuenza virus antigens. There were no titer differences
between the urban and the rural location in our study.
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Inﬂuenza pandemics typically originate when avian or swine
inﬂuenza viruses adapt to humans through reassortment or
mutation. Not every cross-species jump causes an inﬂuenza
pandemic, as seen by the differences last decade between the
sporadic outbreaks of inﬂuenza A/H5N1 and the 2009 A/H1N1
pandemic, which spread worldwide in a matter of weeks. The
current outbreak of subtype A/H7N9 human cases in China [1, 2],
with 130 cases conﬁrmed in <3 months and no conﬁrmation
yet of human-to-human transmission, appears to be more
transmissible from poultry to humans than H5N1 but does not
yet resemble the transmission patterns of the 2009 pandemic.
In any of these epidemiological scenarios, key clinical and epi-
demiological features are difﬁcult to determine during the early
outbreak or epidemic phase, and for this reason pandemic pre-
paredness plans have been put into place globally in an attempt
to mitigate or slow down the ﬁrst stages of the epidemic and to
gather early data.
When a pandemic may be imminent, the key knowledge to
have in place includes the pattern of population immunity
for targeting protective measures and predicting the attack
rate, virological parameters that enable the development of
diagnostic tests and may inform about the effectiveness of
drugs or vaccines, the clinical spectrum of disease, and
the risk for severe infection. Data gathering will be prioritized
differently depending on whether the early epidemio-
logical data represent sporadic animal-to-human transmission
(as with H5N1), consistent animal-to-human transmission
(as with H7N9), or a rapidly spreading pandemic (as with
2009 H1N1).
One aspect of pandemic preparation that has not received
much attention is the analysis of serological data in the early
stages of a pandemic and whether these data can be used to
inform the medical and public health communities about the
immune status of the general population during this critical
period. We address this topic here by presenting general-popu-
lation serological data from an ongoing study in southern
Vietnam, and we suggest the best way to interpret these results
during the context of an emerging pandemic.
BACKGROUND ANDMETHODS
Since 2010, age-stratiﬁed serum sample collections have been
ongoing in the Hospital for Tropical Diseases in Ho Chi Minh
City, Vietnam, and in Khanh Hoa Provincial Hospital in Nha
Trang, 300 km northeast of Ho Chi Minh City. Ho Chi Minh
City is a densely populated major urban center with an ofﬁcial
population of 7.5 million inhabitants. Nha Trang, with a popu-
lation of 400 000, is the capital of Khanh Hoa province, and the
Khanh Hoa Provincial Hospital serves the city of Nha Trang, as
well as the surrounding rural areas. Anonymized and unlinked
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residual serum samples are collected in both hospitals from
routine biochemistry and hematology analysis for the purpose
of measuring inﬂuenza virus antibody titers. The serum samples
are intended to represent the general population in each hospi-
tal’s catchment region, as presentation to the hospital should
not be correlated with history of inﬂuenza virus infection. Sea-
sonal inﬂuenza vaccination in Vietnam is uncommon and there-
fore unlikely to inﬂuence antibody levels. The research protocol
was approved by the Oxford Tropical Research Ethics Commit-
tee at the University of Oxford and by the Scientiﬁc and Ethical
Committee of the Hospital for Tropical Diseases in Ho Chi
Minh City.
A total of 1723 samples were collected between 2010 and
2012—939 from Ho Chi Minh City and 784 from Khanh Hoa
—and were tested for immunoglobulin G antibodies to the
hemagglutinin 1 (HA1) region of 5 avian inﬂuenza viruses and
11 human inﬂuenza viruses (Supplementary Table 1) by a
protein microarray [3–5]. One of the 5 avian inﬂuenza virus an-
tigens was that of the A/Chicken/Netherlands/1/2003 (H7N7)
virus, whose HA1 protein shares 96% homology with the HA1
of the earliest H7N9 strains sequenced in China (A/Shanghai/
2/2013 and A/Anhui/1/2013 [1]). Only 10 amino acid positions
differed between these 2 strains: V38I, T112A, D165N, I170V,
T180A, I193V, I227M, E261G, N289D, and E303R (HA num-
bering as in [2]). The last 2 positions do not appear to be in
regions associated with binding of virus-neutralizing anti-
bodies, and the remaining changes are largely conservative, but
it is difﬁcult to describe the antigenic characteristics of the
viruses on the basis of the mutations alone. Nevertheless, the
high level of homology makes it likely that there would be sub-
stantial serological cross-reaction between the HAs from these
2 viruses.
In addition to the subtype H7 antigen, the microarray in-
cludes 1 subtype H9 antigen and 3 H5 antigens (H5/04, H5/07,
and H5/10; Supplementary Table 1). Serology was performed
on 4-fold dilutions (1:20, 1:80, 1:320, and 1:1280), and antibody
titers were computed by ﬁtting a 4-parameter log-logistic curve
to 8 luminescence readouts (duplicate spots per antigen), using
the curve’s point of inﬂection as the titer measurement for that
sample, as described previously [5]. Antibody titer measure-
ments are continuous in this type of analysis and can fall any-
where between 20 and 1280. Titer measurements that fall
outside this range were given scores of 10 and 1810. The assay
was validated for pandemic 2009 H1N1 inﬂuenza by compar-
ing results with hemagglutination inhibition (HI) assays; reac-
tivity of H5, H7, and H9 antigens was conﬁrmed using sera
from immunized rabbits and chickens [5].
Statistical analysis was performed with R, version 3.0.0
(R Foundation for Statistical Computing, Vienna, Austria), and
MATLAB (Mathworks, Natick, MA). Domestic chicken owner-
ship data were obtained from the Government Statistics Ofﬁce
of Vietnam.
RESULTS
Antibodies binding to subtype H7 antigen are at higher titers
than antibodies binding to H5; titers to H9 were the highest
among the avian antigens. Geometric mean titers (GMTs) were
23.1 for H9 (95% conﬁdence interval [CI], 21.8–24.4), 19.0 for
H7 (95% CI, 18.1–20.0), 13.5 for both H5/10 and H5/07 (95%
CI, 13.1–13.9), and 11.1 for H5/04 (95% CI, 10.9–11.3), while
GMTs for human inﬂuenza virus antigens ranged from 60 to
200. This indicates that immunity to subtype H7 viruses should
be low and comparable to that for other avian inﬂuenza viruses.
The microarray assay is more sensitive than HI or microneu-
tralization tests, but it has not yet been determined whether the
binding differences observed among H5, H7, and H9 translate
to differences in clinical protection. Because titers calculated
from our assay are not directly comparable to HI or microneu-
tralization tests, no cutoff is chosen to represent positivity or
clinical protection. It is not possible to associate these titers
with past exposure or past infection, as serological assays have
not yet been validated for H7N9. On the basis of comparison of
the H7 GMT with that of other antigens on the array, it is rea-
sonable to assume that past exposure to avian H7 viruses is
similar to past exposure to other avian inﬂuenza viruses.
Figure 1 shows quantile-quantile plots for the entire titer dis-
tributions, as well as their top quartiles; top quartiles are shown
because the majority of titers for each antigen were equal to 10
and the upper end of each distribution showed the most varia-
tion. Pair-wise differences between distributions were signiﬁ-
cant by both the Kolmogorov-Smirnov test and Wilcoxon
rank-sum test (all P values were < 10−5), except for the compar-
ison between H5/07 and H5/10, whose titer distributions were
very similar. These relative titers among H9, H7, and H5 are
consistent with some [6, 7] but not all [8, 9] past serological in-
vestigation in various study populations.
Antibody titers to all avian inﬂuenza virus antigens increase
with age, as expected (Figure 2), and this increase is largely ex-
plained by increased antibody titers to human inﬂuenza viruses
(Supplementary Figure 1). If we assume that infections with
avian inﬂuenza viruses are rare, then the most likely explanation
for the titer signals we observe to avian inﬂuenza virus antigens
is cross-reactivity of antibodies generated by past infections with
human inﬂuenza virus [10]. Diversity of inﬂuenza virus antibod-
ies increases with age, as individuals accumulate an antibody
repertoire to their different inﬂuenza virus infections, and it
becomes more likely that these antibody populations are able to
bind antigens from certain avian inﬂuenza viruses [11].
No titer differences between locations were detected in the
data (by the Kolmogorov-Smirnov test and Wilcoxon rank-
sum tests, after generating 100 subsamples without replacement
to match age distributions between the 2 sites; Supplementary
Figure 2), although 38% of households in Khanh Hoa province
keep domestic chickens, compared with 5.4% of households in
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Ho Chi Minh City. It is also plausible that in Khanh Hoa
human inﬂuenza virus exposure is lower than in Ho Chi Minh
City and that avian inﬂuenza virus exposure is higher than in
Ho Chi Minh City. However, Supplementary Figure 1 shows
that regression of the log titer of avian inﬂuenza virus antibody
onto age and the log GMT of human inﬂuenza virus antibodies
does not reveal differences in the regression coefﬁcients by site.
Thus, the data do not show evidence that domestic poultry
ownership has an effect on immunoglobulin G antibody titers
to avian subtype hemagglutinins [12].
DISCUSSION
Although validation of serological assays is impossible in the
early months of a pandemic because of the lack of positive con-
trols, serological measurements can still be informative when
compared across age groups or antigens. The value of compar-
ing antibody titers across antigens in a potentially prepandemic
scenario is that it may alert us to a particularly dangerous situa-
tion in which cross-reactive antibodies to an emerging virus are
lower than we expected; this would have been the case if
Figure 1. Quantile-quantile plots showing comparisons of titer distributions among 5 antigens (n = 1723; upper left). Titer values and speciﬁc antigens
are labeled on both axes. The 10 subplots in the lower-right part of the graph show quantile-quantile plots of the top quartile of individuals (n = 431) with
the highest geometric mean antibody titers across the 5 avian inﬂuenza virus antigens. All pair-wise distribution comparisons show that the distributions
are statistically signiﬁcantly different (all P values are < 10−5, by the Kolmogorov-Smirnov and Wilcoxon rank-sum tests), except for the 2 panels marked
“NS” (ie, not signiﬁcant). Antigen abbreviations are A/Vietnam/1194/2004 (H5/04), A/Cambodia/R0405050/2007 (H5/07), A/Hubei/1/2010 (H5/10), A/
Chicken/Netherlands/1/2003 (H7), and A/Guinea Fowl/Hong Kong/WF10/1999 (H9).
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H7-binding had been weaker than H5-binding in our assays.
With pandemic preparedness in mind, antigen-antigen com-
parisons can also be used to prioritize vaccine development for
H7 viruses over H9 viruses, if the higher titers to H9 can be cor-
related to some level of clinical protection. Comparing antibody
titers across age groups can be useful for pandemic response,
although these results will not always be available in time, as was
the case in 2009 [13].
The perfect seroepidemiological analysis early during a
pandemic would be able to link quantitative differences in
serology to quantitative differences in population transmis-
sion rates, but it will be many years before experimental
and analytical methods are sophisticated enough to estab-
lish this link. For pathogens that confer complete immuni-
ty, this link can be established because the percentage of
completely immune individuals can be equated to the per-
centage reduction in the basic reproduction number of the
pathogen (if mixing patterns are known or assumed to be
uniform). For inﬂuenza, however, antigenic diversity is high
and partial immunity is the norm; thus, it is not currently
possible to link the immunity measured in any inﬂuenza
virus assay to quantitative reductions in susceptibility, viral
replication, or transmissibility.
Prioritizing clinical and epidemiological research is an im-
portant component of pandemic response. If patients, contacts,
and negative controls from the earliest infections can be en-
rolled and followed up for serology, validations for positive and
negative serological results can be ready after 2–3 months, de-
pending on the rate of spread, the case-fatality rate, and enroll-
ment. In 2009, these serological results would have arrived too
late, but for outbreaks involving the less transmissible H7N9
and H5N1 viruses, interpretation of serological ﬁndings could
take place well before an outbreak becomes a pandemic.
If the general-population serological responses in Vietnam
are representative of other countries in East and Southeast Asia,
then the results presented here may tell us something about rel-
ative levels of immune protection in the region. This gives us
another reason to seek better understanding of global inﬂuenza
virus circulation. If the current belief holds that inﬂuenza
viruses circulate and mix globally in short periods (as suggested
by Bahl et al [14] and in articles they cite), then the immuno-
logical landscapes constructed by inﬂuenza epidemics should
be similar across countries. Taking national vaccination pat-
terns into account [15], serological studies from a limited
number of sites could be used to inform the global response. If
a coordinated research response involving serological analysis
is perceived as too difﬁcult logistically or scientiﬁcally, a
simpler solution may be to preempt this need by maintaining
recent serum collections that are either tested or ready for
testing for a broad class of important pathogens.
Population-level immunity appears to be low to inﬂuenza
A/H7N9 and comparable to what we observe for other avian in-
ﬂuenza viruses. In southern Vietnam, we do not see evidence
that the current H7N9 outbreaks represent a tip-of-the-iceberg
observation of widespread H7N9 infection. We observed no
differences between 2 areas with low and high levels of domes-
tic poultry ownership, indicating that poultry ownership does
not have an effect on avian inﬂuenza virus exposure or avian in-
ﬂuenza virus antibody levels. If the H7N9 outbreaks develop
into a human-transmissible epidemic, the current results will
serve as a baseline for interpreting population-level serological
data after the ﬁrst wave of infections.
Figure 2. Scatter plots of antibody titers by antigen and age group. Red lines show 70th, 80th, and 90th quantiles of the data points. A single red line
at 10 indicates that the 70th, 80th, and 90th quantiles of that data set are all equal to 10.
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Supplementary materials are available at The Journal of Infectious Diseases
online (http://jid.oxfordjournals.org/). Supplementary materials consist of
data provided by the author that are published to beneﬁt the reader. The
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